INS and metabolic dysfunction-associated steatotic liver disease: Beyond their structural role in cell membranes, omega-3 PUFAs regulate hepatic lipid metabolism, reducing liver fat accumulation, inflammation, and fibrosis while improving insulin sensitivity and counteracting oxidative stress, highlighting their potential as useful agents for managing NAFLD.